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Abstract. After heart disease, cancer is the most common cause of death in many developed countries. 
Understanding how the overall cancer incidence evolves during economic growth can help macroeconomic 
attempts to forecast the economic impact of cancer and to manage resources allocation in planning health 
services. In this paper, we discuss the relationship between economic growth and cancer incidence. The 
purposes of the paper are to describe and measure the influence of an increasing real per capita income on 
the overall incidence of cancer. Using worldwide cross-sectional data for 162 countries, regression results 
with crude and age-standardised rates, allow us to measure the elasticity of cancer incidence with respect to 
per capita income, and to decompose the elasticity coefficient into two components: age-effect and lifestyle-
effect.  
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1. Introduction 
 
Health is a fundamental dimension of quality of life. In fact, almost all indices of economic and 
social well-being contain at least one variable for measuring health conditions. There are some 
important exceptions, but in the long-run, higher values of real per capita income usually 
correspond to better hygiene and sanitary conditions. During growth, however, each society 
undergoes several important changes in both demand and supply of health care. Thereby, the 
process of economic growth modifies the composition and order of importance of the main 
population health problems. 
This paper analyses one of the foremost of these changes in society’s health problems, and 
focuses on the relationship between economic growth and cancer incidence. In particular, we 
explore this relationship at the macroeconomic level, using worldwide cross-sectional data for 162 
countries in 2002. We attempt to collect some empirical regularities concerning how an increasing 
real per capita income influences the overall incidence of cancer.  
Understanding and measuring how cancer incidence evolves during economic growth can be 
useful for forecasting the economic impact of cancer and for governing the process of resources 
allocation in planning health services. However, it is necessary to emphasise that this is not a study 
about social and economic factors causing cancerous diseases. This paper simply highlights some 
basic empirical regularities and theoretical insights to be considered for further research in order to 
develop an economic theory of cancer incidence. 
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The remainder of the paper is organized as follows. Section 2 briefly introduces three essential 
measures of cancer frequency. Section 3 is devoted to quantitative analysis. Section 4 concludes the 
paper with some suggestion for further research. 
 
 
2. Basic measures of cancer frequency 
 
In order to describe and measure the frequency of cancerous diseases, epidemiology utilises three 
main indicators: incidence, prevalence and mortality. Incidence and mortality are flow variables. 
They indicate the number of new cancer cases and the number of deaths due to cancer, 
respectively, which occur in a specific population over a given period (usually 1 year). Prevalence 
is a stock variable. It indicates the number of cancer cases in a specific population at a given point 
in time (Last, 2001). 
Data on incidence, prevalence and mortality are usually expressed as absolute numbers or as 
rates. Rates can be crude or age-standardised. A crude rate is calculated by dividing the absolute 
number of new cases, cases or deaths by the corresponding number of people in the population at 
risk. An age-standardised rate is a weighted average of the age-specific crude rates, where the 
weights are the proportion of people in the corresponding age groups of a specific standard 
population. These age-adjusted rates are calculated to allow comparison between populations with 
different age structures, and they are particularly useful in making international comparisons. In 
this case, the most frequently used standard population is the world standard population (WHO, 
2003) and the results are usually presented as annual rates per 100,000 persons at risk. 
 Where raw data are regularly collected by local cancer registry, these basic measures of cancer 
frequency can be computed for each type of cancer, usually classified according to the 
International Classification of Diseases (ICD) or for all cancerous diseases as a whole (WHO, 2005). 
In this latter case, epidemiologists usually refer to the overall prevalence rate as a measure of 
society’s cancer burden. In the same way, since incidence is regarded as a useful approximation to 
the average risk of developing any type of cancer, the overall incidence rate is considered as an 
index of the level of cancer risk factors that exist in a given society, during a given period. Finally, 
the overall mortality rate provides an approximation to the average risk of dying from some type 
of cancer. 
 
 
3. Some international evidence 
 
Economic growth can affect cancer incidence, prevalence and mortality in various ways. In this 
paper we focus on the influence of a long-term increase in real per capita income on the overall 
incidence rate of all types of cancer. 
Using data from the World Bank (WB) and the World Health Organization (WHO), we develop 
an empirical analysis of the relationship between economic growth and cancer incidence. For this 
purpose, we use cross-sectional data on per capita income and cancer incidence in 2002, for 162 
countries included in WB and WHO statistical databases, and for a subset of these 162 countries, 
which consist of a more homogeneous group of 41 countries, that are characterised by a “Western 
lifestyle”. In this subset there are 36 European countries plus Australia, Canada, New Zealand and 
the USA (from now, we simply refer to the whole set as the World group and to the subset as the 
Western group). 
More particularly, real per capita income is measured by the ratio of GNI to population and it is 
expressed in current international dollars, using purchasing power parity (PPP) rates (World Bank, 
2004). Cancer incidence is measured by the crude and the age-standardised rates of all types of 
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cancer (“all sites, but non melanoma skin”, according to the ICD classification) provided by the 
WHO within Globocan project (Bray et al., 2004). In fact, International Agency for Research on 
Cancer (IARC) publishes free software with worldwide estimation of cancer incidence, prevalence 
and mortality. For cancer incidence, these data include absolute numbers of new cancer cases, and 
crude and age-standardised rates, in both the male and female population. 
Table 1 contains a short description and some basic descriptive statistics of all variables for the 
two groups of countries (the complete database is available from the author). 
As a useful starting point to highlight this issue, in Figures 1 and 2, the crude rate of incidence 
of all types of cancers within the total population (TCR) is plotted against the per capita income (Y) 
for all 162 countries and for the subset of 41 countries. Both scatter plots seem to suggest a strong 
influence of real per capita income on the average risk of developing some type of cancer.  
In order to measure the magnitude of this influence, Tables 2 and 3 show the results of ordinary 
least square (OLS) estimations of the relationship TCR = f(Y) in three different specifications: linear, 
quadratic and double-log. The goodness of fit is fairly high in all equations. The crude rate shows a 
strong positive and significant relationship with per capita income, but it tends to increase less 
than proportionally with respect to Y. In other words, during economic growth the crude rate of 
cancer incidence increases, but it evolves drawing approximately the early stage of an inverted U-
shaped curve. Indeed, the quadratic and double-log forms are the two specifications that best fit 
data for the World and Western groups, respectively. 
This analysis, however, neglects the powerful influence of sex and age on cancer incidence. 
Thus, it is necessary to repeat OLS estimation using crude and age-standardised rates (ASR), in 
both the male and female populations (again in linear, quadratic and double-log specifications). 
The simple decomposition of crude rate by sex does not alter the previous results (as shown in 
Tables 2 and 3). Instead, using age-standardised rates there is a slight reduction in the goodness of 
fit. Changes in per capita income, however, continue to explain an important part of the change in 
cancer incidence. This effect is not due to the positive influence of economic growth on the average 
duration of life. 
In particular, a straight line best describes the relationship between real per capita income and 
cancer incidence within the female population in both groups of data, while quadratic and double-
log forms provide a reasonably close approximation to data for the male population in countries 
within the World and Western groups, respectively. All this seems to confirm a relevant negative 
effect of economic growth on the presence of cancer risk factors in different populations. 
 
 
3.1. Income elasticity of cancer incidence 
 
These results suggest that economic growth has a negative influence on cancer incidence, but they 
also indicate that in some cases cancer incidence tends to rise less than proportionally with respect 
to the increase in real per capita income. Moreover, the negative effect of economic growth on the 
overall rate of cancer incidence seems to be only partially related to the implications of an ageing 
population. Results of our regressions on crude and age-standardised rates indicate that there are 
both a gross and a net effect of economic growth on cancer incidence, respectively. 
Regression models using the double-log specification allow us to easily calculate the elasticity of 
cancer incidence with respect to real per capita income. These coefficients provide an idea of the 
dimensions of both gross and net effects of economic growth on cancer incidence.  
As shown in Table 4, all elasticities are positive but less than one. On average, the coefficient is 
about 0.4 for countries within the World group and 0.2 for those within the Western group. 
Differences in elasticity between these two groups, however, are mainly due to the effect of 
economic growth on the average life expectation at birth. As a matter of fact, using the age-
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standardised rates cancer incidence increases, on average, by 0.23 and 0,16% in the World and 
Western groups, respectively, for each 1% increase in real per capita income. 
Finally, using regression results from the quadratic specification, we can calculate the average 
hypothetical threshold level of Y (that is, the real per capita income beyond which cancer incidence 
starts diminishing, Y*). As shown in Table 4, in a long-run perspective, the process of economic 
growth may tend to exhaust the strong net negative effect on cancer incidence. However, our 
results within the male population indicate that this threshold level of real per capita income is 
extremely high (about $33,000 and $35,000  for the World and Western groups, respectively). 
 
 
4. Conclusions 
 
Describing and measuring the relationship between cancer incidence and real per capita income 
constitutes the first step in understanding how the process of economic growth affects population 
exposure to cancer causing factors.  
In fact, real per capita income is not an accurate and adequate measure of a country’s level of 
development and it is not possible to summarize in Y a set of economic, social and health features. 
Further research is needed to include more variables, as for example, those referring to personal 
income distribution, cultural habits and customs, general sanitary conditions and health policies. It 
is also necessary to utilise epidemiological data for each type of cancer within more homogeneous 
genetic populations.  
This paper, however, highlights some basic empirical regularities and theoretical insights that 
may be useful in developing an economic theory of the evolution of cancer incidence in a growing 
economy. 
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Table 1 - Variables and Summary Statistics
Description Variable Mean Std. Dev. Min Max
World group (n = 162)
Per Capita Gross National Income Y 8.166,90 8.937,60 500,00 37.270,00
Total (Female and Male), Incidence Crude Rate TCR 183,83 139,25 44,70 507,99
Female, Incidence Crude Rate FCR 178,45 124,30 58,90 496,40
Female, Incidence Age-Standardized Rate FASR 163,03 53,30 77,90 308,70
Male, Incidence Crude Rate MCR 190,24 156,56 36,00 585,80
Male, Incidence Age-Standardized Rate MASR 187,67 80,30 64,90 406,60
Western group (n = 41)
Per Capita Gross National Income Y 18.515,00 10.325,70 1.620,00 37.270,00
Total (Female and Male), Incidence Crude Rate TCR 388,02 85,18 198,09 507,99
Female, Incidence Crude Rate FCR 359,98 78,71 196,70 496,40
Female, Incidence Age-Standardized Rate FASR 224,04 40,51 160,60 308,70
Male, Incidence Crude Rate MCR 419,35 98,78 196,00 585,80
Male, Incidence Age-Standardized Rate MASR 290,26 47,89 206,50 406,60
Y, Current International Dollars, Purchasing Power Parity - PPP, 2002 (World Bank, 2004)
CR and ASR, Crude and Age-Standardized Rates for all types of cancers: all sites but non-melanoma skin
(C00-C96, but C44, International Classification of Diseases ICD)
Incidence Rates per 100,000 persons, 2002 (International Agency for Research on Cancer, 2004)
Countries in the "Western gruoup": Albania, Austria, Belarus, Belgium, Bosnia and Herz, Bulgaria, Croatia, Czech rep
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta
Nethederlands, Norway, Poland, Portugal, Rep. Moldova, Romania, Russian Fed., Serbia and Mont., Slovakia
Slovenia, Spain. Sweden, Switzerland, TFYR Macedonia, United Kingdom, Ukraine, Australia, Canada, New Zealand, USA  
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Table 2 - Regression results, World group
Dependent R - Bar Heteroskedasticy* Functional Form**
variable Regressor Coefficient T-Ratio Prob Squared CHSQ LM Version CHSQ LM Version n
Total (Female and male) Crude Rate
01 TCR Constant 75,52 9,67 0,72 0,920 [0,337] 9,063 [0,003] 162
Y 0,132 20,52
02 TCR Constant 53,13 5,04 0,74 1,184 [0,276] 0,235 [0,627] 162
Y 0,020 8,70
Y2 -2,27E-07 -3,06
03 LogTCR Constant 0,286 2,45 0,01 0,61 0,010 [0,918] 21,66 [0,000] 162
LogY 0,508 16,09
Female Crude rate
04 FCR Constant 81,43 11,79 0,73 1,206 [0,272] 7,730 [0,005] 162
Y 0,012 20,80
05 FCR Constant 63,15 6,74 0,74 1,859 [0,173] 0,035 [0,850] 162
Y 0,017 8,52
Y2 -1,86E-07 -2,82
06 LogFCR Constant 0,463 4,38 0,68 0,145 [0,703] 22,52 [0,000] 162
LogY 0,462 16,19
Male Crude rate
07 MCR Constant 68,76 7,77 0,72 2,610 [0,106] 9,75 [0,002] 162
Y 0,148 20,33
08 MCR Constant 42,48 3,57 0,73 3,000 [0,083] 0,617 [0,432] 162
Y 0,023 8,78
Y2 -2,67E-07 -3,19
09 LogMCR Constant 0,095 0,75 0,45 0,62 0,392 [0,531] 21,17 [0,000] 162
LogY 0,558 16,21
Female Age-Standardized Rate
10 FASR Constant 127,46 32,74 0,53 0,013 [0,907] 0,830 [0,362] 162
Y 0,043 13,52
11 FASR Constant 124,08 23,00 0,53 0,005 [0,940] 0,117 [0,732] 162
Y 0,0054 4,56
Y2 -3,43E-08 -0,90 0,37
12 LogFASR Constant 1,515 22,43 0,38 0,607 [0,436] 18,28 [0,000] 162
LogY 0,184 10,06
Male Age-Standardized Rate
13 MASR Constant 132,48 23,41 0,56 0,087 [0,768] 10,63 [0,001] 162
Y 0,0067 14,43
14 MASR Constant 114,93 15,13 0,59 0,003 [0,958] 0,465 [0,495] 162
Y 0,012 7,28
Y2 -1,78E-07 -3,34
15 LogMASR Constant 1,232 14,75 0,47 6,O39 [0,014 ] 12,98 [0,000] 162
LogY 0,273 12,08
* Based on the regression of sqared residuals on squared fitted values 
** Ramsey's RESET test using the squares of the fitted values  
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Table 3 - Regression results, Western group
Dependent R - Bar Heteroskedasticy* Functional Form**
variable Regressor Coefficient T-Ratio Prob Squared CHSQ LM Version CHSQ LM Version n
Total (Female and male) Crude Rate
01 TCR Constant 268,50 15,44 0,60 0,233 [0,629] 6,305 [0,012] 41
Y 0,0064 7,85
02 TCR Constant 208,45 7,44 0,65 0,039 [0,842] 1,976 [0,160] 41
Y 0,0156 4,36
Y2 -2,48E-07 -2,62 0,01
03 LogTCR Constant 1,449 12,48 0,70 0,615 [0,433] 0,103 [0,748] 41
LogY 0,270 9,75
Female Crude rate
04 FCR Constant 246,55 16,06 0,64 0,194 [0,659] 3,942 [0,047] 41
Y 0,0061 8,43
05 FCR Constant 204,61 8,00 0,66 0,043 [0,834] 1,177 [0,278] 41
Y 0,0120 3,83
Y2 -1,73E-07 -2,01 0,05
06 LogFCR Constant 1,438 12,62 0,70 1,116 [0,291] 0,122 [0,727] 41
LogY 0,265 9,75
Male Crude rate
07 MCR Constant 288,21 13,24 0,54 0,028 [0,867] 6,902 [0,009] 41
Y 0,0071 6,87
08 MCR Constant 209,54 6,03 0,60 0,906 [0,341] 1,353 [0,245] 41
Y 0,0192 4,30
Y2 -3,25E-07 -2,77 0,01
09 LogMCR Constant 1,440 10,75 0,65 0,112 [0,737] 0,327 [0,567] 41
LogY 0,280 8,75
Female Age-Standardized Rate
10 FASR Constant 169,13 19,45 0,56 0,013 [0,907] 0,018 [0,892] 41
Y 0,0029 7,21
11 FASR Constant 170,75 11,21 0,55 0,023 [0,878] 0,030 [0,862] 41
Y 0,0027 1,39 0,17
Y2 6,71E-09 0,13 0,89
12 LogFASR Constant 1,598 13,92 0,51 0,542 [0,462] 3,968 [0,046] 41
LogY 0,178 6,50
Male Age-Standardized Rate
13 MASR Constant 239,14 18,95 0,34 0,014 [0,906] 1,253 [0,263] 41
Y 0,0027 4,62
14 MASR Constant 219,72 10,09 0,34 0,219 [0,640] 3,911 [0,048] 41
Y 0,0057 2,05 0,04
Y2 -8,02E-08 -1,09 0,28
15 LogMASR Constant 1,847 16,37 0,41 0,055 [0,814] 0,015 [0,969] 41
LogY 0,146 5,42
* Based on the regression of sqared residuals on squared fitted values 
** Ramsey's RESET test using the squares of the fitted values  
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Table 4 - Elasticties and Income Turning Points
World World Western Western
Variable elasticity Y*, PPP (2002) elasticity Y*, PPP (2002)
01 - TCR 0,508 44.053 0,270 31.452
02 - FCR 0,462 45.773 0,265 34.642
03 - MCR 0,558 42.697 0,280 29.548
Mean CR 0,510 44.235 0,273 32.095
04 - FASR 0,184 -- 0,178 --
05 - MASR 0,273 33.632 0,146 35.532
Mean ASR 0,229 -- 0,162 --
All observations
Mean 0,397 41.539 0,228 32.793
Std. Dev. 0,151 4.845 0,058 2.431
 
 
 
 
 
 
 
Economic growth and Cancer Incidence (World group, 2002)
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Economic growth and Cancer Incidence (Western group, 2002)
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Figure 2 
 
